Table 2

Prevalence rates of potential systemic corticosteroid-induced comorbidity and comparisons by groups in the OPCRD dataset

MorbiditySevere asthma (%) (n=808)Mild/moderate asthma (%) (n=3975)OR (95% CI)*p Value*Non-asthma controls (%) (n=2412)OR (95% CI)*p Value*
Type II diabetes82 (10)281 (7)1.46 (1.11 to 1.91)0.006149 (6)1.76 (1.30 to 2.38)<0.001
Obesity (BMI >30 kg/m2)339 (42)1385 (35)1.36 (1.16 to 1.59)<0.001561 (23)2.04 (1.74 to 2.39)<0.001
Osteopenia78 (10)85 (2)5.26 (3.75 to 7.37)<0.00141 (2)6.68 (4.28 to 10.43)<0.001
Osteoporosis126 (16)162 (4)5.23 (3.97 to 6.89)<0.00174 (3)6.53 (4.63 to 9.21)<0.001
Fracture41 (5)134 (3)1.54 (1.06 to 2.22)0.02288 (4)1.65 (1.14 to 2.39)0.007
Dyspeptic disorders524 (65)1331 (34)3.99 (3.37 to 4.72)<0.001578 (24)4.88 (4.11 to 5.79)<0.001
Glaucoma32 (4)137 (3)1.12 (0.75 to 1.68)0.5867 (3)1.41 (0.89 to 2.25)0.15
Cataract70 (9)195 (5)1.89 (1.39 to 2.56)<0.001105 (4)2.42 (1.70 to 3.43)<0.001
Cardiovascular disease77 (10)277 (7)1.36 (1.02 to 1.81)0.035168 (7)1.57 (1.14 to 2.15)0.005
Hypertension276 (34)1145 (29)1.35 (1.12 to 1.61)0.001596 (25)1.76 (1.44 to 2.14)<0.001
Psychiatric conditions/anxiety/depression310 (38)1238 (31)1.43 (1.22 to 1.69)<0.001607 (25)1.67 (1.42 to 1.97)<0.001
Hypercholesterolaemia124 (15)561 (14)1.15 (0.92 to 1.44)0.21258 (11)1.61 (1.25 to 2.08)<0.001
Sleep disorder33 (4)99 (2.5)1.70 (1.13 to 2.53)0.01040 (2)2.21 (1.46 to 3.35)<0.001
Chronic kidney disease110 (14)342 (9)1.80 (1.39 to 2.32)<0.001167 (7)2.41 (1.81 to 3.21)<0.001
  • *OR (95% CI) and p values are calculated for the severe asthma cohort relative to each of the other two groups.

  • BMI, body mass index; OPCRD, Optimum Patient Care Research Database.